Related topics

cancer treatment (1)

RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
Ajax Therapeutics Inc
United States
 Blood cancer biotech. Series C USD 95,000,000

MOST ACTIVE INVESTORS

Goldman Sachs Alternative Investments 1
Eli Lilly & Co 1
Vivo Capital LLC 1
RA Capital Management 1
Point72 Capital Management LLC 1
EcoR1 Capital 1
Boxer Capital LLC 1
Schrödinger Inc US 1
Inning One Ventures 1

BEST FUNDED


Ajax Therapeutics Inc
United States
Blood cancer biotech.